Human Metabolome Technologies, Inc. Stock
Equities
6090
JP3794530000
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
645 JPY | -0.77% | -2.57% | +0.78% |
Sales 2022 | 1.22B 7.96M | Sales 2023 | 1.3B 8.45M | Capitalization | 4.42B 28.79M |
---|---|---|---|---|---|
Net income 2022 | 267M 1.74M | Net income 2023 | 285M 1.85M | EV / Sales 2022 | 2.48 x |
Net cash position 2022 | 1.27B 8.28M | Net cash position 2023 | 1.43B 9.3M | EV / Sales 2023 | 2.31 x |
P/E ratio 2022 |
16.1
x | P/E ratio 2023 |
15.5
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
1.34% | Free-Float | 80.56% |
1 day | -0.77% | ||
1 week | -2.57% | ||
Current month | -1.53% | ||
1 month | -0.31% | ||
3 months | -3.15% | ||
6 months | -5.84% | ||
Current year | +0.78% |
Managers | Title | Age | Since |
---|---|---|---|
President | 55 | 18-02-28 | |
Tomomi Ishihara
ADM | Chief Administrative Officer | - | - |
Takaomi Fukuhara
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yasuhiro Ohata
BRD | Director/Board Member | 59 | 20-06-30 |
Corporate Officer/Principal | 49 | 05-06-30 | |
Toshio Nagae
BRD | Director/Board Member | 80 | 17-06-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 645 | -0.77% | 3 500 |
24-05-01 | 650 | -0.61% | 6,500 |
24-04-30 | 654 | -0.15% | 5,300 |
24-04-26 | 655 | -1.06% | 8,000 |
24-04-25 | 662 | +0.46% | 1,900 |
Delayed Quote Japan Exchange, May 02, 2024 at 02:00 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+0.78% | 24.4M | |
+23.39% | 42.68B | |
-3.00% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+8.11% | 24.94B | |
-19.85% | 18.96B | |
+29.71% | 12.3B | |
-3.30% | 11.95B | |
-2.33% | 11.55B |
- Stock Market
- Equities
- 6090 Stock